BR112016030375A8 - uso de um composto no tratamento ou melhora da enxaqueca, no tratamento, supressão e/ou prevenção da depressão cortical e no tratamento ou melhora de uma lesão cerebral traumática - Google Patents
uso de um composto no tratamento ou melhora da enxaqueca, no tratamento, supressão e/ou prevenção da depressão cortical e no tratamento ou melhora de uma lesão cerebral traumáticaInfo
- Publication number
- BR112016030375A8 BR112016030375A8 BR112016030375A BR112016030375A BR112016030375A8 BR 112016030375 A8 BR112016030375 A8 BR 112016030375A8 BR 112016030375 A BR112016030375 A BR 112016030375A BR 112016030375 A BR112016030375 A BR 112016030375A BR 112016030375 A8 BR112016030375 A8 BR 112016030375A8
- Authority
- BR
- Brazil
- Prior art keywords
- migraine
- treatment
- methods
- amelioration
- treating
- Prior art date
Links
- 206010027599 migraine Diseases 0.000 title abstract 10
- 208000019695 Migraine disease Diseases 0.000 title abstract 8
- 230000001054 cortical effect Effects 0.000 title abstract 3
- 208000030886 Traumatic Brain injury Diseases 0.000 title abstract 2
- 230000009529 traumatic brain injury Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
- 239000004031 partial agonist Substances 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000006561 Cluster Headache Diseases 0.000 abstract 1
- 208000005056 Ophthalmoplegic Migraine Diseases 0.000 abstract 1
- 206010052784 Retinal migraine Diseases 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 208000018912 cluster headache syndrome Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000001667 episodic effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462015727P | 2014-06-23 | 2014-06-23 | |
| US201562109386P | 2015-01-29 | 2015-01-29 | |
| PCT/US2015/037177 WO2015200322A1 (en) | 2014-06-23 | 2015-06-23 | Methods of treating or ameliorating migraine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112016030375A2 BR112016030375A2 (pt) | 2017-08-15 |
| BR112016030375A8 true BR112016030375A8 (pt) | 2021-07-13 |
Family
ID=54938737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016030375A BR112016030375A8 (pt) | 2014-06-23 | 2015-06-23 | uso de um composto no tratamento ou melhora da enxaqueca, no tratamento, supressão e/ou prevenção da depressão cortical e no tratamento ou melhora de uma lesão cerebral traumática |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3157943A4 (https=) |
| JP (2) | JP6688748B2 (https=) |
| KR (1) | KR20170018072A (https=) |
| CN (1) | CN106661085A (https=) |
| AU (1) | AU2015280108B2 (https=) |
| BR (1) | BR112016030375A8 (https=) |
| CA (1) | CA2953170A1 (https=) |
| MX (1) | MX2016017388A (https=) |
| RU (1) | RU2721401C2 (https=) |
| WO (1) | WO2015200322A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7476229B2 (ja) * | 2019-04-15 | 2024-04-30 | フェリン・ファーマシューティカルズ・インコーポレイテッド | 片頭痛の治療 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006468A1 (en) * | 1993-09-01 | 1995-03-09 | Smithkline Beecham Corporation | Method for treating migraine headaches |
| DE60131032T2 (de) * | 2000-08-25 | 2008-08-14 | Research Corp. Technologies, Inc., Tucson | Verwendung von antikonvulsiven Aminosäure zur Behandlung von Migräne |
| EP1337559A2 (en) * | 2000-11-17 | 2003-08-27 | Bayer Ag | Regulation of human nmda receptor |
| ES2381091T3 (es) * | 2003-03-06 | 2012-05-23 | Botulinum Toxin Research Associates, Inc. | Tratamiento del dolor facial crónico y cefalea relacionados con la sinusitis con toxina botulínica |
| NZ590793A (en) * | 2008-07-23 | 2012-07-27 | Kyowa Hakko Kirin Co Ltd | Therapeutic agent for migraine |
| WO2011003064A2 (en) * | 2009-07-02 | 2011-01-06 | Naurex, Inc. | Methods of treating neuropathic pain |
| US8951968B2 (en) * | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| PL2485751T3 (pl) * | 2009-10-05 | 2014-10-31 | Univ Northwestern | GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie |
| CN105037492A (zh) * | 2010-02-11 | 2015-11-11 | 西北大学 | 二级结构稳定化的nmda受体调节剂及其用途 |
| US20140107037A1 (en) * | 2011-04-27 | 2014-04-17 | Northwestern University | Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders |
| US20150253305A1 (en) * | 2012-10-12 | 2015-09-10 | Northwestern University | Methods of identifying compounds for treating depression and other related diseases |
-
2015
- 2015-06-23 CN CN201580033913.6A patent/CN106661085A/zh active Pending
- 2015-06-23 WO PCT/US2015/037177 patent/WO2015200322A1/en not_active Ceased
- 2015-06-23 CA CA2953170A patent/CA2953170A1/en not_active Abandoned
- 2015-06-23 JP JP2016575106A patent/JP6688748B2/ja active Active
- 2015-06-23 AU AU2015280108A patent/AU2015280108B2/en not_active Ceased
- 2015-06-23 BR BR112016030375A patent/BR112016030375A8/pt not_active IP Right Cessation
- 2015-06-23 EP EP15811633.5A patent/EP3157943A4/en not_active Withdrawn
- 2015-06-23 MX MX2016017388A patent/MX2016017388A/es unknown
- 2015-06-23 KR KR1020177001848A patent/KR20170018072A/ko not_active Ceased
- 2015-06-23 RU RU2017101410A patent/RU2721401C2/ru active
-
2020
- 2020-04-06 JP JP2020068289A patent/JP2020114863A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016030375A2 (pt) | 2017-08-15 |
| JP2017519778A (ja) | 2017-07-20 |
| CA2953170A1 (en) | 2015-12-30 |
| MX2016017388A (es) | 2018-02-19 |
| RU2017101410A3 (https=) | 2019-01-21 |
| CN106661085A (zh) | 2017-05-10 |
| AU2015280108B2 (en) | 2019-11-28 |
| KR20170018072A (ko) | 2017-02-15 |
| RU2017101410A (ru) | 2018-07-24 |
| WO2015200322A1 (en) | 2015-12-30 |
| JP2020114863A (ja) | 2020-07-30 |
| AU2015280108A1 (en) | 2017-01-19 |
| EP3157943A4 (en) | 2018-01-24 |
| RU2721401C2 (ru) | 2020-05-19 |
| EP3157943A1 (en) | 2017-04-26 |
| JP6688748B2 (ja) | 2020-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501969A1 (en) | Pharmaceutical composition comprising empagliflozin and uses thereof | |
| BR112018004532A2 (pt) | uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos | |
| MX2018013003A (es) | Oligonucleotidos para tratar una enfermedad ocular. | |
| DOP2017000268A (es) | Metodos y kits para tratar depresion | |
| MX2016010854A (es) | Metodos para el tratamiento o la prevencion del asma mediante la administracion de un antagonista de il-4r. | |
| MX2018003388A (es) | Agonistas del receptor farnesoide x y usos de los mismos. | |
| MX2017015938A (es) | Inhibidores de ezh2 para el tratar linfomas. | |
| MX2023000796A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
| MX2019010994A (es) | Metodos para tratar enfermedades y trastornos mediados por el complemento. | |
| EA201892657A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
| BR112014010803A2 (pt) | método de tratamento | |
| BR112016024850A2 (pt) | composições e métodos para modulação da expressão 3 semelhante a antiopoietina | |
| BR112015009948A8 (pt) | Antagonistas de ativina-actrii, usos dos mesmos para tratamento de doenças ósseas e outros distúrbios e método para monitorar a eficácia do tratamento ou prevenção de uma doença óssea e outros distúrbios | |
| WO2014190163A3 (en) | Combination therapy for mds | |
| MX2022007221A (es) | Compuestos y composiciones para el tratamiento o prevencion de trastornos patologicos asociados con exceso de deposicion de fibrina y/o formacion de trombos. | |
| BR112017018964A2 (pt) | uso de plinabulin e métodos para tratar tumor cerebral | |
| EA201990424A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
| ZA202000375B (en) | Compounds for the prevention and treatment of medical disorders and uses thereof | |
| MX382757B (es) | Inhibidor del sistema complemento de ornithodoros moubata para utilizarse en el tratamiento de enfermedades mediadas por el sistema complemento en pacientes con polimorfismo de c5. | |
| EA201990428A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
| MX2016008108A (es) | Angiotensina ii sola o en combinacion para el tratamiento de hipotension. | |
| BR112016017886A8 (pt) | grelina ou variantes ou derivados da mesma, e, usos da grelina | |
| MX2020004497A (es) | Administracion oral de analogos del peptido glp-1. | |
| CL2019000625A1 (es) | Combinación de agonistas de fxr. | |
| WO2016134257A8 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2676 DE 19-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |